Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infections | D007239 | EFO_0000544 | — | 1 | — | — | — | — | 1 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | 1 | — | — | — | — | 1 |
Communicable diseases | D003141 | — | — | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Bacterial infections | D001424 | — | A49 | 1 | — | — | — | — | 1 |
Gram-negative bacterial infections | D016905 | — | — | 1 | — | — | — | — | 1 |
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Drug common name | Nacubactam |
INN | nacubactam |
Description | Nacubactam is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | beta-lactamase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NCCONC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O |
PDB | — |
CAS-ID | 1452458-86-4 |
RxCUI | — |
ChEMBL ID | CHEMBL3989959 |
ChEBI ID | — |
PubChem CID | 73386748 |
DrugBank | DB15353 |
UNII ID | 832O37V7MZ (ChemIDplus, GSRS) |